2021
DOI: 10.1007/978-3-030-50488-5
|View full text |Cite
|
Sign up to set email alerts
|

Optimal Impulsive Control for Cancer Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 19 publications
0
6
0
Order By: Relevance
“…Nonetheless, two issues arise in this case, it is not biologically feasible to constantly applied an immunotherapy treatment to a cancer patient and it is evident that the solution of the effector T cells goes to the value 256,596 cells/μL (a concentration close to that of the the maximum carrying capacity of the CML cancer cells) which could produce adverse events in the patient’s health [ 36 ]. Hence, in order to avoid the latter, numerous authors have proposed different treatment strategies to apply therapies such as chemotherapy, radiotherapy and immunotherapy by time intervals or in the form of periodic oscillations, one can see [ 14 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 ]. Thus, our hypothesis is as follows: Daily applications for a finite period of time of the immunotherapy treatment will decrease the CML cancer cells concentration below a critical threshold under which it is possible to ensure the complete eradication of the disease.…”
Section: Discussion and In Silico Experimentationmentioning
confidence: 99%
“…Nonetheless, two issues arise in this case, it is not biologically feasible to constantly applied an immunotherapy treatment to a cancer patient and it is evident that the solution of the effector T cells goes to the value 256,596 cells/μL (a concentration close to that of the the maximum carrying capacity of the CML cancer cells) which could produce adverse events in the patient’s health [ 36 ]. Hence, in order to avoid the latter, numerous authors have proposed different treatment strategies to apply therapies such as chemotherapy, radiotherapy and immunotherapy by time intervals or in the form of periodic oscillations, one can see [ 14 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 ]. Thus, our hypothesis is as follows: Daily applications for a finite period of time of the immunotherapy treatment will decrease the CML cancer cells concentration below a critical threshold under which it is possible to ensure the complete eradication of the disease.…”
Section: Discussion and In Silico Experimentationmentioning
confidence: 99%
“…Furthermore, we have fixed the chances to execute the impulsive interventions, while they can also become additional variables to be optimized. Theoretically, the adaptive timing approach that has been employed for impulse control problems of ordinary differential equations arising in cancer therapy [15] can be extended to our case. However, its computational cost needs to be carefully evaluated.…”
Section: Discussionmentioning
confidence: 99%
“…In summary, to compute the optimal control * u , what we should do is to solve the adjoint equation(s) (12) backward in time starting from the terminal condition (15) with the internal boundary conditions (32) and (38). The optimal control is given by (36) as a quantity determined from the adjoint variables ( ) i p .…”
Section: Optimality Conditionmentioning
confidence: 99%
“…Various schemes have been proposed in the literature, which aim to optimize the time instants of the treatment, the amount of drug administered to the patient, or even both [1,2]. Some recent results involve impulsive systems, reinforcement learning, or other model-based approaches [3][4][5][6]. e proper mathematical treatment of the problem often involves impulsive control actions, which has been researched extensively [7,8] and has vast importance in cases where the drug is administered by injections.…”
Section: Introductionmentioning
confidence: 99%
“…e main contribution of our work is that we show the viability of model-based metronomic therapy in in vivo using mice experiments. Since the vast majority of current research in model-based chemotherapy optimization mostly demonstrates in silico results [2,3,10], an experimental validation showing the feasibility of the approach can bring more attention to this field from other researchers.…”
Section: Introductionmentioning
confidence: 99%